MSLN and digestive system neoplasm: Third, we focused on MSLN-positive tumor cell lines (such as HGC27, MKN45, NCI-N87, and CFPAC-1) to assess antitumor efficacy, concentrating on gastrointestinal tumors, which may limit the generalizability of our findings.